椎体成形术在治疗脊椎骨质疏松压缩性骨折中的应用

Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic compression fractures of vertebra

目的 评价经皮椎体内注入骨水泥 (聚甲基丙烯酸甲酯 )治疗脊椎骨质疏松压缩性骨折的临床价值。方法 自 2 0 0 1年 8月起 ,对 16例 19个椎体的骨质疏松压缩性骨折的患者使用经皮椎体内注射骨水泥 ,行椎体成形术。结果 术后 1～ 2d所有患者的疼痛消失或明显减轻 ,3d内均下床活动。随访 1～ 7个月 (平均 4.6个月 ) ,无疼痛复发。术中、术后无严重并发症。结论 经皮椎体内注入骨水泥治疗脊椎骨质疏松压缩性骨折是一种简单、安全。

Objective To evaluate the therapeutic effects of percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic compression fractures. Methods Clinical data of 16 patients with vertebral osteoporotic compression fractures treated with percutaneous polymethylmethacrylate vertebroplasty were analyzed retrospectively. Results All patients had significant or complete relief with their low back pain 12 days after the treatment, and could get up and move 3 days after the surgery. During the 17 months(average 4.6 months) follow up period , pain recurrence was not complained in all of these patients and none of them experienced severe complication after the treatment. Conclusion Percutaneous polymethylmethacrylate vertebroplasty provide an effective,reliable, and significant pain relief in the patients with osteoporotic compression fractures of vertebra.